Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-renal Fenoldopam for Early AKI
NCT01073189Phase 4Withdrawn
- Sponsor
- Southeast Renal Research Institute
- Start
- Apr 2010
- Primary completion
- Jan 2011
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fenoldopam in acute kidney injury (AKI), sponsored by Southeast Renal Research Institute. Planned start Apr 2010; status: withdrawn.
02
Drugs
fenoldopam
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01073189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01073189.